Jane is the Foundation Director of the Australian Centre for Behavioural Research in Diabetes – a partnership for better health between Diabetes Victoria and Deakin University – and holds the Chair in Behavioural and Social Research in Diabetes, Deakin University.
Jane has a PhD in health psychology from Royal Holloway, University of London, is a chartered psychologist, a Fellow of the British Psychological Society and a Fellow of the Royal Society of Medicine.
Jane has published 130+ peerreviewed journal articles, several book chapters, and 180+ conference presentations. Google Scholar indicates there have been >3500 citations of her work. Over the past decade, Jane has been an investigator on research attracting funds of $65 million, with over $60 million achieved since 2012, including the EU IMI2 4-year HypoRESOLVE grant (2018-2022), and UK NIHR 5.5 year DAFNEplus (2016-2021), and the NHMRC GP-OSMOTIC trial (2016-2018).
Her research translation achievements include being a founding member of the DAFNE (‘dose adjustment for normal eating’) education program, which has trained more than 43,500 adults with type 1 diabetes in the UK since 2001, more than 3,200 in Australia/New Zealand since 2005 (OzDAFNE), and is also available in Kuwait and Singapore. On behalf of Diabetes Australia, she is the NDSS Leader for the Mental Health and Diabetes National Priority Area, and also for the Starting Insulin in Type 2 Diabetes National Priority Area. In 2011, Jane led the development of the Diabetes Australia position statement: A new language for diabetes’, which has ignited an international movement focused on improving the language used in communicating with and about people with diabetes.
Jane’s principle research interests focus broadly on improving the quality of life of people with diabetes and optimising their self-care. Her research includes developing, evaluating and enhancing provision of structured diabetes education; restoring impaired awareness of hypoglycaemia and preventing recurrent severe hypoglycaemia; expectations, experiences and optimisation of new diabetes treatments and technologies; the experience of social stigma related to diabetes; monitoring and reducing diabetes-related distress; investigating the needs of specific populations, e.g. young adults with type 2 diabetes, adolescents with type 1 diabetes, women with diabetes planning and during pregnancy. Jane is widely regarded as an authority on the development, use and interpretation of measures of psychological processes and outcomes in diabetes, also known as patient-reported outcomes (PROs).
T:+61 (0)3 5227 8415